These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 28618923)
1. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer. Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923 [TBL] [Abstract][Full Text] [Related]
2. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer. Wang P; Qin J; Ye H; Li L; Wang X; Zhang J J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480 [TBL] [Abstract][Full Text] [Related]
4. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma. Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004 [TBL] [Abstract][Full Text] [Related]
5. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer. Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955 [TBL] [Abstract][Full Text] [Related]
6. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936 [TBL] [Abstract][Full Text] [Related]
8. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer. Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875 [TBL] [Abstract][Full Text] [Related]
9. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer]. Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769 [TBL] [Abstract][Full Text] [Related]
10. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma. Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952 [TBL] [Abstract][Full Text] [Related]
11. Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer. Duan Y; Cui C; Qiu C; Sun G; Wang X; Wang P; Ye H; Dai L; Shi J Dis Markers; 2022; 2022():6657820. PubMed ID: 35273656 [TBL] [Abstract][Full Text] [Related]
12. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876 [TBL] [Abstract][Full Text] [Related]
13. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer. Anderson KS; Wong J; Vitonis A; Crum CP; Sluss PM; Labaer J; Cramer D Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):859-68. PubMed ID: 20200435 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877 [TBL] [Abstract][Full Text] [Related]
15. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma. Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146 [TBL] [Abstract][Full Text] [Related]
16. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838 [TBL] [Abstract][Full Text] [Related]
17. Multi-panel assay of serum autoantibodies in colorectal cancer. Ushigome M; Nabeya Y; Soda H; Takiguchi N; Kuwajima A; Tagawa M; Matsushita K; Koike J; Funahashi K; Shimada H Int J Clin Oncol; 2018 Oct; 23(5):917-923. PubMed ID: 29691673 [TBL] [Abstract][Full Text] [Related]
18. Comparison of candidate serologic markers for type I and type II ovarian cancer. Lu D; Kuhn E; Bristow RE; Giuntoli RL; Kjær SK; Shih IeM; Roden RB Gynecol Oncol; 2011 Sep; 122(3):560-6. PubMed ID: 21704359 [TBL] [Abstract][Full Text] [Related]
19. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer. Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118 [TBL] [Abstract][Full Text] [Related]
20. Autoantibody biomarkers for the detection of serous ovarian cancer. Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]